1. Home
  2. OGN vs NPO Comparison

OGN vs NPO Comparison

Compare OGN & NPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • NPO
  • Stock Information
  • Founded
  • OGN 1923
  • NPO 2002
  • Country
  • OGN United States
  • NPO United States
  • Employees
  • OGN N/A
  • NPO N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • NPO Metal Fabrications
  • Sector
  • OGN Health Care
  • NPO Industrials
  • Exchange
  • OGN Nasdaq
  • NPO Nasdaq
  • Market Cap
  • OGN 2.5B
  • NPO 3.9B
  • IPO Year
  • OGN N/A
  • NPO N/A
  • Fundamental
  • Price
  • OGN $9.93
  • NPO $204.19
  • Analyst Decision
  • OGN Hold
  • NPO Buy
  • Analyst Count
  • OGN 4
  • NPO 2
  • Target Price
  • OGN $18.00
  • NPO $202.50
  • AVG Volume (30 Days)
  • OGN 3.6M
  • NPO 133.6K
  • Earning Date
  • OGN 08-05-2025
  • NPO 08-05-2025
  • Dividend Yield
  • OGN 0.80%
  • NPO 0.61%
  • EPS Growth
  • OGN N/A
  • NPO N/A
  • EPS
  • OGN 2.88
  • NPO 4.01
  • Revenue
  • OGN $6,294,000,000.00
  • NPO $1,064,400,000.00
  • Revenue This Year
  • OGN N/A
  • NPO $4.99
  • Revenue Next Year
  • OGN $1.11
  • NPO $5.27
  • P/E Ratio
  • OGN $3.45
  • NPO $50.72
  • Revenue Growth
  • OGN N/A
  • NPO 2.92
  • 52 Week Low
  • OGN $8.01
  • NPO $133.50
  • 52 Week High
  • OGN $23.10
  • NPO $214.58
  • Technical
  • Relative Strength Index (RSI)
  • OGN 51.13
  • NPO 64.08
  • Support Level
  • OGN $9.71
  • NPO $198.25
  • Resistance Level
  • OGN $10.27
  • NPO $207.02
  • Average True Range (ATR)
  • OGN 0.37
  • NPO 4.47
  • MACD
  • OGN 0.01
  • NPO 0.59
  • Stochastic Oscillator
  • OGN 48.48
  • NPO 84.40

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About NPO Enpro Inc.

Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through three segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.

Share on Social Networks: